Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 12, 2010, Pages 1973-1983

  Beffy, Pascale ^a   Del Carratore, Renata ^a   Masini, Matilde ^b   Furling, Denis ^c   Puymirat, Jack ^d   Masiello, Pellegrino ^b   Simili, Marcella ^a  

^a CNR   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SORBONNE UNIVERSITÉ   (France)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

ATG5; Autophagy; Congenital myotonic dystrophy type 1; Electron microscopy; Glycogen accumulation; LC3; Myoblasts differentiation; P53; P70S6K; Signal transduction pathways

Indexed keywords

AUTOPHAGY PROTEIN 5; GLYCOGEN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; PROTEIN P70;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DIFFERENTIATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METABOLIC STRESS; MYOBLAST; MYOTONIC DYSTROPHY; SIGNAL TRANSDUCTION;

AUTOPHAGY; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; IMMUNOBLOTTING; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MYOBLASTS; MYOD PROTEIN; MYOGENIN; MYOTONIC DYSTROPHY; SIGNAL TRANSDUCTION;

EID: 78149282920     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.08.010     Document Type: Article

References (66)

1. Amack J.D., Reagan S.R., Mahadevan M.S. Mutant DMPK 3′-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. J Cell Biol 2002, 159:419-429.
2. Amack J.D., Mahadevan M.S. Myogenic defects in myotonic dystrophy. Dev Biol 2004, 265:294-301.
3. Astrom K.E., Adams R.D. Myotonic disorders. Skeletal muscle pathology 1982, 266-286. Churchill Livingstone, Edinburgh. F.L. Mastaglia, J. Walton (Eds.).
4. Aucello M., Dobrowolny G., Musarò A. Localized accumulation of oxidative stress causes muscle atrophy through activation of an autophagic pathway. Autophagy 2009, 5:527-529.
5. Beffy P., Barsanti C., Del Carratore R., Simi S., Benedetti P.A., Benzi L., et al. Expression and localization of myotonic dystrophy protein kinase in human skeletal muscle cells determined with a novel antibody: possible role of the protein in cytoskeleton rearrangements during differentiation. Cell Biol Int 2005, 29:742-753.
6. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808.
7. Colell A., Ricci J.E., Tait S., Milasta S., Maurer U., Bouchier-Hayes L., et al. GAPDH and autophagy preserve cellular survival during caspase-independent cell death. Cell 2007, 129:983-997.
8. Conejo R., Valverde A.M., Benito M., Lorenzo M. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities. J Cell Physiol 2001, 186:82-94.
9. Davies B.M., McCurrach M.E., Taneja K.L., Singer R.H., Housman D.E. Expansion of a trinucleotide CUG repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci USA 1997, 94:7388-7393.
10. Dorman C.M., Johnson S.E. Activated Raf inhibits avian myogenesis through a MAPK-dependent mechanism. Oncogene 1999, 18:5167-5176.
11. Dunn W.A. Autophagy and related mechanisms of lysosome-mediated protein degradation. Trends Cell Biol 1994, 4:139-143.
12. Dunne P.W., Ma L., Casey D.L., Harati Y., Epstein H.F. Localization of myotonic dystrophy protein kinase in skeletal muscle and its alteration with disease. Cell Motil Cytoskeleton 1996, 33:52-63.
13. Edwards M.G., Anderson R.M., Yuan M., Kendziorski C.M., Weindruch R., Prolla T.A. Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program. BMC Genomics 2007, 23(8):80.
14. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75(4):817-825.
15. Eskelinen E.-L. Maturation of autophagic vacuoles in mammalian cells. Autophagy 2005, 1:1-10.
16. Farkas E., Tomé F.M., Fardeau M., Arsénio-Nunes M.L., Dreyfus P., Diebler M.F. Histochemical and ultrastructural study of muscle biopsies in 3 cases of dystrophia myotonica in the newborn child. J Neurol Sci 1974, 21(March (3)):273-288.
17. Feng Z., Zhang H., Jin L.S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005, 102:8204-8209.
18. Fingar D.C., Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004, 23:3151-3171.
19. Furling D., Coiffier L., Mouly V., Barbet J.P., St Guily J.L., Taneja K., et al. Defective satellite cells in congenital myotonic dystrophy. Hum Mol Genet 2001, 10:2079-2087.
20. Furling D., Lemieux D., Taneja K., Puymirat J. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul Disord 2001, 11:728-735.
21. Furling D., Marette A., Puymirat J. Insulin-like growth factor I circumvents defective insulin action in human myotonic dystrophy skeletal muscle cells. Endocrinology 1999, 140:4244-4250.
22. Gallo R., Gambelli F., Gava B., Sasselli F., Tellone V., Masini M., et al. Generation and expansion of multipotent mesenchimal progenitor cells from cultured from cultured human pancreatic islets. Cell Death Differ 2007, 14:1860-1871.
23. Hamshere M.G., Newman E.E., Alwazzan M., Athwal B.S., Brook J.D. Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighbouring genes. Proc Natl Acad Sci USA 1997, 94:7394-7399.
24. Han J.W., Pearson R., Dennis P.B., Thomas G. Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites. J Biol Chem 1995, 270:21396-21403.
25. Han J., Jiang Y., Li Z., Kravchenko V.V., Ulevitch R.J. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 1997, 2:296-299.
26. Ho T.H., Bundman D., Armstrong D.L., Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 2005, 14:1539-1547.
27. Joulia D., Bernardi H., Garandel V., Rabenoelina F., Vernus B., Cabello G. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 2003, 286:263-275.
28. Kirisako T., Ichimura Y., Kabeya Y., Mizushima N., Yoshimori T., Oshumi M., et al. The reversible modification regulates the membrane-binding state of Apq8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J Cell Biol 2000, 151:263-276.
29. Kuma A., Hatano M., Matsui M., Yamamoto A., Nakaya H., Hoshimori T., et al. The role of autophagy during the early neonatal starvation period. Nature 2004, 432:1032-1036.
30. Langlois M., Lee N.S., Rossi J.J., Puymirat J. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts. Mol Ther 2003, 7:670-680.
31. Laurent D., Hundal R.S., Dresner A., Price T.B., Vogel S.M., Petersen K.F., et al. Mechanism of muscle glycogen autoregulation in humans. Am J Physiol Endocrinol Metab 2000, 278:663-668.
32. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
33. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004, 6:463-477.
34. Lluis F., Ballestar E., Suelves M., Esteller M., Muñoz-Cánoves P. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J 2005, 24:974-984.
35. Lluís F., Perdiguero E., Nebreda A.R., Munoz-Canoves P. Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol 2006, 16:36-44.
36. Ludatscher R.M., Kerner H., Amikam S., Gellei B. Myotonia dystrophica with heart involvement: an electron microscopic study of skeletal, cardiac, and smooth muscle. J Clin Pathol 1978, 31:1057-1064.
37. Lum J.J., Bauer D.E., Kong M., Harris M.H., Li C., Lindsten T., et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005, 120:237-248.
38. Luo S., Rubinsztein D.C. Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ 2007, 14(7):1247-1250.
39. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007, 8:741-752.
40. Maiuri M.C., Galluzzi L., Morselli E., Kepp O., Malik S.A., Kroemer G. Autophagy regulation by p53. Curr Opin Cell Biol 2009, 22:1-5.
41. Messina G., Blasi C., La Rocca S.A., Pompili M., Calconi A., Grossi M. p27Kip1 acts downstream of N-cadherin-mediated cell adhesion to promote myogenesis beyond cell cycle regulation. Mol Biol Cell 2005, 16:1469-1480.
42. Migheli A., Mongini T., Doriguzzi C., Chiado-Piat L., Riva P., Ugo I., et al. Muscle apoptosis in humans occurs in normal and denervated muscle, but not in myotonic dystrophy, dystrophinopathies or inflammatory disease. Neurogenetics 1997, 1:81-87.
43. Molkentin J.D., Olson E.N. Defining the regulatory networks for muscle development. Curr Opin Genet Dev 1996, 6:445-453.
44. Moxley R.T., Griggs R.C., Goldblatt D. Muscle insulin resistance in myotonic dystrophy: effect of supraphysiologic insulinization. Neurology 1980, 30:1077-1083.
45. Nielsen N., Vissing J., Wojtaszewski J.F.P., Haller R.G., Begum N., Richter E.A. Decreased insulin action in skeletal muscle from patients with McArdle's disease. Am J Physiol Endocrinol Metab 2002, 282:1267-1275.
46. O'Brien T.A., Harper P.S. Course, prognosis and complications of childhood-onset myotonic dystrophy. Dev Med Child Neurol 1984, 26:62-67.
47. Oude Ophuis R.J.A., Wijers M., Bennink M.B., van de Loo F.A.J., Fransen J.A.M., Wieringa B., et al. A tail-anchored myotonic dystrophy protein kinase isoform induces perinuclear clustering of mitochondria, autophagy, and apoptosis. Plos ONE 2009, 4(11):e8024.
48. Perry R.L., Parker M.H., Rudnicki M.A. Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol Cell 2001, 8:291-301.
49. Reddy S., Smith D.B., Rich M.M., Leferovich J.M., Reilly P., Davis B.M., et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 1996, 13:325-335.
50. Rivard N., Boucher M.J., Asselin C., L'Allemain G. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. Am J Physiol Cell Physiol 1999, 277:652-664.
51. Sahgal V., Bernes S., Sahgal S., Lischwey C., Subramani V. Skeletal muscle in preterm infants with congenital myotonic dystrophy. Morphologic and histochemical study. J Neurol Sci 1983, 59:47-55.
52. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001, 29:40-47.
53. Seznec H., Agbulut O., Sergeant N., Savouret C., Ghestem A., Tabti N., et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 2001, 10:2717-2726.
54. Swash M., Fox K.P. Abnormal intrafusal muscle fibres in myotonic dystrophy; a study using serial sections. J Neurol Neurosurg Psychiatry 1975, 38:91-99.
55. Takahashi A., Ohtani N., Yamakoshi K., Iida S., Tahara H., Nakayama K., et al. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 2006, 8:1291-1297.
56. Tapscott S.J. The circuitry of a master switch: MyoD and the regulation of skeletal muscle gene transcription. Development 2005, 132:2685-2695.
57. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science 1998, 281:1312-1316.
58. Timchenko N.A., Cai Z.J., Welm A.L., Reddy S., Ashizawa T., Timchenko L.T. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 2001, 276:7820-7826.
59. Timchenko N.A., Iakova P., Cai Z.J., Smith J.R., Timchenko L.T. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 2001, 21:6927-6938.
60. Ueda H., Shimokawa M., Yamamoto M., Kameda N., Mizusawa H., Baba T., et al. Decreased expression of myotonic dystrophy protein kinase and disorganization of sarcoplasmic reticulum in skeletal muscle of myotonic dystrophy. J Neurol Sci 1999, 162:38-50.
61. Wang G.S., Kuyumcu-Martinez M.N., Sarma S., Mathur N., Wehrens X.H., Cooper T.A. PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type. J Clin Invest 2009, 119:3797-3806.
62. Weibel E.R. Stereological methods: practical methods for biological morphometry 1979, vol. 1. Acad. Press, New York.
63. Wu Z., Woodring P.J., Bhakta K.S., Tamura K., Wen F., Feramisco J.R., et al. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 2000, 20:3951-3964.
64. Yu L., Wan F., Dutta S., Welsh S., Liu Z., Freundt E., et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci USA 2006, 103:4952-4957.
65. Zetser A., Gredinger E., Bengala E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem 1999, 274:5193-5200.
66. KIP2 control muscle differentiation at the myogenin step. Genes Dev 1999, 13:213-224.